MGMT hypermethylation: a prognostic foe, a predictive friend.
about
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerDeregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targetsO(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problemsTransfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agentsMGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer casesPolymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.Absence of MGMT promoter methylation in endometrial cancerExpression of O-Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian PatientsPrognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaEpigenetic alterations in liver of C57BL/6J mice after short-term inhalational exposure to 1,3-butadiene.Polish natural bee honeys are anti-proliferative and anti-metastatic agents in human glioblastoma multiforme U87MG cell lineGrowth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.The significance of MGMT protein detection in evaluation of osteosarcoma necrosis rate after cisplatin chemotherapyDiethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.Prospects for epigenetic epidemiology.Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA.Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinomaThe promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.DNA repair gene variants in relation to overall cancer risk: a population-based studyExpression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide.Epigenetic changes in gliomas.A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept, Roche): overview.Promoter CpG island methylation markers in colorectal cancer: the road ahead.MGMT testing for glioma in clinical laboratories: discordance with methylation analyses prevents the implementation of routine immunohistochemistry.Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.Emerging drugs for acromegaly.Epigenetic biomarkers: potential applications in gastrointestinal cancersDetoxification of oxidative stress in glioma stem cells: mechanism, clinical relevance, and therapeutic development.p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ.Research on DNA methylation of human osteosarcoma cell MGMT and its relationship with cell resistance to alkylating agents.Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma.MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patientsMethMarker: user-friendly design and optimization of gene-specific DNA methylation assays.Comparison of chemoradiotherapy with radiotherapy alone for "biopsy only" anaplastic astrocytoma.Persistent organic pollutants and promoter hypermethylation of the O(6)-methylguanine-DNA methyltransferase gene.Heavy metals effect on breast cancer progression.
P2860
Q26766285-34DF443D-21B2-4139-81FE-8AA6FB6ED84CQ26829873-5F796F6A-8B10-4CB7-AAE9-623932E8FFC2Q26853112-0A248D99-497C-4F50-98AF-F55DFBC07D54Q28273012-CCC57F0F-45E4-4D4A-BB8D-6A852D7E00B8Q33750187-722592E9-8DEE-4728-9BC3-CE8001D00A9EQ33904061-40F69AB5-876F-410B-800E-B260E25A3BE7Q34171450-C1D82CE0-7CA6-415E-8A01-896EC1F7A869Q34218598-32BE949E-D69D-44B4-8515-5B4622F9D804Q34486212-88BBB716-3F7F-4A88-B7CB-836A9662D73FQ34980960-F995436F-0CD2-4477-BC1B-5C8AE79124A2Q35110867-14CBB968-23D0-4BE0-B31A-96C267AC46D6Q35179525-9FF113E3-FCA4-4E8C-9206-1BE19FEF39BFQ35184772-0908FC91-CB0E-44C1-A8D6-6D2D78703102Q35730616-5E2D98B3-6E6E-463E-AEFF-62AD9ABDC247Q35792273-C7897D3F-A829-4514-AB66-90887ED1A0A7Q36016070-2955C0D5-3223-4760-9CAD-14E74093CE52Q36209738-941ABA9D-4838-4C34-87C6-5ED5F7A96D72Q36216177-F68F35F7-A914-4729-954C-FB3A20C17CCEQ36225952-57943CB0-3953-4CDE-B452-76A1540483B6Q36259173-5C7F659A-80D1-4A17-87C8-C344C84987ECQ36499747-B821CC19-2D0F-4E99-8B23-B0364C88BAF8Q37061545-63D7EC89-99F8-4D43-879D-6D81A71D03B9Q37287032-5489C7C2-8361-4B9B-8E84-7BBF9D086BEFQ37295241-860D3BAF-AB41-4BAA-8E9E-0D44F3E54448Q37309889-9135A285-B75C-4479-8C60-0C33F9E26D83Q37318132-30FC94D7-529E-436A-8CCC-1C4704280E80Q37997086-ADADF2F3-69C2-4CD0-9113-0C5C29BAEF4DQ38044236-43BF5A48-81ED-46A9-9AB3-6AEC3AED585BQ38101368-ADB13B5C-5A99-4129-AF58-C98227D36A22Q38176659-4735A32E-92F2-4C18-84F7-8E653E2C31FEQ38204377-A11768E1-8C78-44D5-9D5C-49DECB3C34ECQ38231884-1F1BFC7A-DF13-4C1F-8FCE-3FE5368A2959Q38908554-CE8B3F0C-8863-4174-AB07-975954A637DBQ39125285-7B8C1AE7-0318-4758-95B7-A72F224ED745Q40978153-3C53F7C5-7C81-4F3B-946E-AC3AE40E8D58Q41612255-5BBBA1E3-D3DD-4C5F-BB29-709AB6E3EEE3Q41965853-7AC6BF5C-6B67-4F75-B776-7A9E68D0CB01Q42366659-A944BAA0-1862-48AE-AB8F-62003A871196Q42702889-B23945E3-85B7-49FE-BB22-98EB52383118Q46209209-8BBBE4FB-C6FC-4396-BCE4-3E29E6544545
P2860
MGMT hypermethylation: a prognostic foe, a predictive friend.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
MGMT hypermethylation: a prognostic foe, a predictive friend.
@ast
MGMT hypermethylation: a prognostic foe, a predictive friend.
@en
MGMT hypermethylation: a prognostic foe, a predictive friend.
@nl
type
label
MGMT hypermethylation: a prognostic foe, a predictive friend.
@ast
MGMT hypermethylation: a prognostic foe, a predictive friend.
@en
MGMT hypermethylation: a prognostic foe, a predictive friend.
@nl
prefLabel
MGMT hypermethylation: a prognostic foe, a predictive friend.
@ast
MGMT hypermethylation: a prognostic foe, a predictive friend.
@en
MGMT hypermethylation: a prognostic foe, a predictive friend.
@nl
P1433
P1476
MGMT hypermethylation: a prognostic foe, a predictive friend.
@en
P2093
Filipe V Jacinto
P304
P356
10.1016/J.DNAREP.2007.03.013
P577
2007-05-07T00:00:00Z